share_log

PersonalAIze And RenovaroCube Announce A Strategic Partnership To Develop, Validate, And Commercialize Cube's AI-Driven Platform For Early Detection Of Cancer And Other Diseases

PersonalAIzeとRenovaroCubeは、がんやその他の病気の早期検知のためのCubeのAI駆動型プラットフォームの開発、検証、商業化を共同で行うための戦略的パートナーシップを発表しました。

Benzinga ·  09/19 09:04

(NASDAQ:RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube's AI-driven, multi-omic platform for early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutions.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする